Omega-3

Clinical evidence: 3 studies 2019–2019

1. Benefit observedRandomized controlled trial8,179 participantsCirculation & Triglycerides

   Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

   New England Journal of Medicine2019View source ↗
2. No benefit observedRandomized controlled trial25,871 participantsCirculation & Triglycerides

   Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

   New England Journal of Medicine2019View source ↗
3. Benefit observedScientific advisory reportCirculation & Triglycerides

   Omega-3 Fatty Acids for the Management of Hypertriglyceridemia

   Circulation2019View source ↗